Build Your Comparison

Side-by-side financial analysis
PROV logo
PROV
ICE logo
ICE
JPM logo
JPM
KO logo
KO
CME logo
CME
Try popular comparisons:

Stock Comparison

PROV vs ICE vs JPM vs KO vs CME

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PROV
Provident Financial Holdings, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$109M
5Y Perf.+27.6%
ICE
Intercontinental Exchange, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNYSE • US
Market Cap$79.60B
5Y Perf.+53.4%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$355.61B
5Y Perf.+84.9%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$97.79B
5Y Perf.+65.8%

PROV vs ICE vs JPM vs KO vs CME — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PROV logoPROV
ICE logoICE
JPM logoJPM
KO logoKO
CME logoCME
IndustryBanks - RegionalFinancial - Data & Stock ExchangesBanks - DiversifiedBeverages - Non-AlcoholicFinancial - Data & Stock Exchanges
Market Cap$109M$79.60B$896.00B$355.61B$97.79B
Revenue (TTM)$60M$12.64B$280.33B$49.28B$6.76B
Net Income (TTM)$7M$3.30B$57.05B$13.70B$4.24B
Gross Margin67.8%61.9%60.0%61.7%86.3%
Operating Margin16.2%38.7%25.9%29.3%65.6%
Forward P/E15.4x17.3x14.4x25.3x22.0x
Total Debt$213M$20.28B$942.38B$45.49B$3.76B
Cash & Equiv.$53M$837M$343.34B$10.27B$4.42B

PROV vs ICE vs JPM vs KO vs CMELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PROV
ICE
JPM
KO
CME
StockJun 20Jun 26Return
Provident Financial… (PROV)100127.6+27.6%
Intercontinental Ex… (ICE)100153.4+53.4%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
The Coca-Cola Compa… (KO)100184.9+84.9%
CME Group Inc. (CME)100165.8+65.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: PROV vs ICE vs JPM vs KO vs CME

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM and CME are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. CME Group Inc. is the stronger pick specifically for profitability and margin quality and dividend income and shareholder returns. PROV, ICE, and KO also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
PROV
Provident Financial Holdings, Inc.
The Banking Pick

PROV ranks third and is worth considering specifically for income & stability and defensive.

  • Dividend streak 0 yrs, beta 0.21, yield 3.3%
  • Beta 0.21, yield 3.3%, current ratio 0.06x
  • NIM 2.8% vs JPM's 2.2%
  • Beta 0.21 vs JPM's 0.94, lower leverage
Best for: income & stability and defensive
ICE
Intercontinental Exchange, Inc.
The Banking Pick

ICE is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 7.5%, EPS growth 20.7%
  • Lower volatility, beta 0.35, Low D/E 69.9%, current ratio 1.02x
  • 7.5% NII/revenue growth vs KO's 1.9%
Best for: growth exposure and sleep-well-at-night
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM has the current edge in this matchup, primarily because of its strength in long-term compounding and valuation efficiency.

  • 465.8% 10Y total return vs CME's 262.4%
  • PEG 0.81 vs KO's 2.26
  • Lower P/E (14.4x vs 22.0x), PEG 0.81 vs 1.60
  • +21.8% vs ICE's -20.4%
Best for: long-term compounding and valuation efficiency
KO
The Coca-Cola Company
The Niche Pick

KO is the clearest fit if your priority is efficiency.

  • 13.1% ROA vs PROV's 0.5%, ROIC 15.8% vs 1.9%
Best for: efficiency
CME
CME Group Inc.
The Banking Pick

CME is the #2 pick in this set and the best alternative if quality and dividends is your priority.

  • 62.8% margin vs PROV's 11.0%
  • 4.1% yield, 15-year raise streak, vs KO's 2.5%
Best for: quality and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthICE logoICE7.5% NII/revenue growth vs KO's 1.9%
ValueJPM logoJPMLower P/E (14.4x vs 22.0x), PEG 0.81 vs 1.60
Quality / MarginsCME logoCME62.8% margin vs PROV's 11.0%
Stability / SafetyPROV logoPROVBeta 0.21 vs JPM's 0.94, lower leverage
DividendsCME logoCME4.1% yield, 15-year raise streak, vs KO's 2.5%
Momentum (1Y)JPM logoJPM+21.8% vs ICE's -20.4%
Efficiency (ROA)KO logoKO13.1% ROA vs PROV's 0.5%, ROIC 15.8% vs 1.9%

PROV vs ICE vs JPM vs KO vs CME — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Fintech Stocks Theme

These companies are key players in the Fintech Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
PROVProvident Financial Holdings, Inc.
FY 2025
Debit Card
53.2%$1M
Deposit Account
46.8%$1M
ICEIntercontinental Exchange, Inc.
FY 2025
Fixed Income And Data Services Segment
51.1%$1.4B
Exchanges Segment
38.8%$1.0B
Mortgage Technology Segment
10.1%$269M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M

PROV vs ICE vs JPM vs KO vs CME — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGICE

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 4661.3x PROV's $60M. CME is the more profitable business, keeping 62.8% of every revenue dollar as net income compared to PROV's 11.0%.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CME logoCMECME Group Inc.
RevenueTrailing 12 months$60M$12.6B$280.3B$49.3B$6.8B
EBITDAEarnings before interest/tax$12M$6.5B$81.4B$15.5B$4.7B
Net IncomeAfter-tax profit$7M$3.3B$57.0B$13.7B$4.2B
Free Cash FlowCash after capex$9M$4.3B$100.9B$12.6B$4.4B
Gross MarginGross profit ÷ Revenue+67.8%+61.9%+60.0%+61.7%+86.3%
Operating MarginEBIT ÷ Revenue+16.2%+38.7%+25.9%+29.3%+65.6%
Net MarginNet income ÷ Revenue+11.0%+26.1%+20.4%+27.8%+62.8%
FCF MarginFCF ÷ Revenue+15.3%+33.9%+36.0%+25.5%+64.4%
Rev. Growth (YoY)Latest quarter vs prior year+12.1%
EPS Growth (YoY)Latest quarter vs prior year+69.2%+23.1%+16.0%+18.2%+21.4%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

JPM leads this category, winning 4 of 7 comparable metrics.

At 16.0x trailing earnings, JPM trades at a 41% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs ICE's 2.74x — a lower PEG means you pay less per unit of expected earnings growth.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CME logoCMECME Group Inc.
Market CapShares × price$109M$79.6B$896.0B$355.6B$97.8B
Enterprise ValueMkt cap + debt − cash$269M$99.0B$1.50T$390.8B$97.1B
Trailing P/EPrice ÷ TTM EPS18.40x24.36x16.00x27.18x24.15x
Forward P/EPrice ÷ next-FY EPS est.15.41x17.34x14.40x25.27x21.98x
PEG RatioP/E ÷ EPS growth rate2.74x0.90x2.43x1.76x
EV / EBITDAEnterprise value multiple21.77x15.34x18.36x26.39x21.56x
Price / SalesMarket cap ÷ Revenue1.81x6.30x3.20x7.42x15.00x
Price / BookPrice ÷ Book value/share0.90x2.77x2.47x10.40x3.38x
Price / FCFMarket cap ÷ FCF13.38x18.56x8.88x67.15x23.32x
JPM leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 4 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $5 for PROV. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs CME's 5/9, reflecting strong financial health.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CME logoCMECME Group Inc.
ROE (TTM)Return on equity+5.1%+11.6%+15.9%+41.1%+15.3%
ROA (TTM)Return on assets+0.5%+2.3%+1.3%+13.1%+2.2%
ROICReturn on invested capital+1.9%+7.5%+4.5%+15.8%+10.2%
ROCEReturn on capital employed+2.4%+9.5%+8.9%+17.3%+3.6%
Piotroski ScoreFundamental quality 0–969575
Debt / EquityFinancial leverage1.66x0.70x2.60x1.33x0.13x
Net DebtTotal debt minus cash$160M$19.4B$599.0B$35.2B-$666M
Cash & Equiv.Liquid assets$53M$837M$343.3B$10.3B$4.4B
Total DebtShort + long-term debt$213M$20.3B$942.4B$45.5B$3.8B
Interest CoverageEBIT ÷ Interest expense0.47x6.53x0.74x10.70x41.55x
KO leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $11,816 for PROV. Over the past 12 months, JPM leads with a +21.8% total return vs ICE's -20.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs ICE's 10.4% — a key indicator of consistent wealth creation.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CME logoCMECME Group Inc.
YTD ReturnYear-to-date+8.8%-11.8%-0.5%+20.3%+3.2%
1-Year ReturnPast 12 months+14.5%-20.4%+21.8%+17.2%+3.6%
3-Year ReturnCumulative with dividends+50.9%+34.6%+138.2%+47.0%+67.9%
5-Year ReturnCumulative with dividends+18.2%+30.9%+118.2%+65.6%+46.2%
10-Year ReturnCumulative with dividends+25.8%+195.3%+465.8%+121.1%+262.4%
CAGR (3Y)Annualised 3-year return+14.7%+10.4%+33.6%+13.7%+18.9%
JPM leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — KO and CME each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs ICE's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CME logoCMECME Group Inc.
Beta (5Y)Sensitivity to S&P 5000.21x0.35x0.94x-0.20x-0.28x
52-Week HighHighest price in past year$17.42$189.35$337.25$84.04$329.16
52-Week LowLowest price in past year$14.95$136.67$262.71$65.35$244.56
% of 52W HighCurrent price vs 52-week peak+98.2%+74.2%+95.1%+98.3%+81.9%
RSI (14)Momentum oscillator 0–10048.831.959.160.640.1
Avg Volume (50D)Average daily shares traded8K3.2M7.0M12.7M2.6M
Evenly matched — KO and CME each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — KO and CME each lead in 1 of 2 comparable metrics.

Analyst consensus: PROV as "Hold", ICE as "Buy", JPM as "Buy", KO as "Buy", CME as "Hold". Consensus price targets imply 38.0% upside for ICE (target: $194) vs -6.5% for PROV (target: $16). For income investors, CME offers the higher dividend yield at 4.05% vs ICE's 1.38%.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CME logoCMECME Group Inc.
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuyHold
Price TargetConsensus 12-month target$16.00$194.00$339.75$86.13$320.80
# AnalystsCovering analysts1036614836
Dividend YieldAnnual dividend ÷ price+3.3%+1.4%+1.9%+2.5%+4.1%
Dividend StreakConsecutive years of raises013155615
Dividend / ShareAnnual DPS$0.56$1.93$5.95$2.04$10.92
Buyback YieldShare repurchases ÷ mkt cap+4.1%+1.7%+3.9%+0.2%+0.3%
Evenly matched — KO and CME each lead in 1 of 2 comparable metrics.
Key Takeaway

JPM leads in 2 of 6 categories (Valuation Metrics, Total Returns). CME leads in 1 (Income & Cash Flow). 2 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 2 of 6 categories
Loading custom metrics...

PROV vs ICE vs JPM vs KO vs CME: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PROV or ICE or JPM or KO or CME a better buy right now?

For growth investors, Intercontinental Exchange, Inc.

(ICE) is the stronger pick with 7. 5% revenue growth year-over-year, versus 1. 9% for The Coca-Cola Company (KO). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PROV or ICE or JPM or KO or CME?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus The Coca-Cola Company at 27. 2x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus The Coca-Cola Company's 2. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — PROV or ICE or JPM or KO or CME?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to +18. 2% for Provident Financial Holdings, Inc. (PROV). Over 10 years, the gap is even starker: JPM returned +465. 8% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PROV or ICE or JPM or KO or CME?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 28β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -435% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PROV or ICE or JPM or KO or CME?

By revenue growth (latest reported year), Intercontinental Exchange, Inc.

(ICE) is pulling ahead at 7. 5% versus 1. 9% for The Coca-Cola Company (KO). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PROV or ICE or JPM or KO or CME?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 14. 8% for PROV. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PROV or ICE or JPM or KO or CME more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus The Coca-Cola Company's 2. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 25. 3x for The Coca-Cola Company — 10. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICE: 38. 0% to $194. 00.

08

Which pays a better dividend — PROV or ICE or JPM or KO or CME?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 4. 1%, versus 1. 4% for Intercontinental Exchange, Inc. (ICE).

09

Is PROV or ICE or JPM or KO or CME better for a retirement portfolio?

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 4. 1% yield, +262. 4% 10Y return). Both have compounded well over 10 years (CME: +262. 4%, JPM: +465. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PROV and ICE and JPM and KO and CME?

These companies operate in different sectors (PROV (Financial Services) and ICE (Financial Services) and JPM (Financial Services) and KO (Consumer Defensive) and CME (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PROV is a small-cap income-oriented stock; ICE is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock; KO is a large-cap quality compounder stock; CME is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.